RVTY - NEW YORK STOCK EXCHANGE, INC.
Industry: Life Sciences Tools & Services
Market Cap: 10.9 B
IPO Date: Jul 6, 1965
Country: US
Currency: USD
Shares Outstanding: 120.2 M
5/9/2025
Discover why Revvity remains a 'buy' despite biotech funding cuts and sector challenges.
Source: SeekingAlpha
5/8/2025
Revvity Inc. stock outperforms competitors on strong trading day
Source: MarketWatch
5/7/2025
Revvity Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Source: MarketWatch
5/6/2025
Revvity Inc. stock outperforms competitors despite losses on the day
Source: MarketWatch
5/6/2025
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Source: Yahoo
5/5/2025
Revvity Inc. stock underperforms Monday when compared to competitors
Source: MarketWatch
5/2/2025
Revvity Inc. stock rises Friday, still underperforms market
Source: MarketWatch
5/1/2025
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Source: Yahoo
4/30/2025
Revvity Inc. stock underperforms Wednesday when compared to competitors
Source: MarketWatch
4/30/2025
WALTHAM, Mass., April 30, 2025--Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:
Source: Yahoo
4/30/2025
Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market hours. Here’s what investors should know.
Source: Yahoo
4/29/2025
Revvity ( NYSE:RVTY ) First Quarter 2025 Results Key Financial Results Revenue: US$664.8m (up 2.3% from 1Q 2024). Net...
Source: Yahoo
4/29/2025
Companies In The News Are: DPZ, RVTY, OPRA, INMD.
Source: Yahoo
4/29/2025
Revvity Inc (RVTY) reports a robust Q1 2025 performance, exceeding EPS expectations and demonstrating resilience amidst macroeconomic challenges.
Source: Yahoo
4/28/2025
Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.
Source: Yahoo
4/28/2025
Revvity reported first-quarter earnings that topped analysts' estimates.
Source: Yahoo
4/28/2025
While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Source: Yahoo
4/28/2025
Revvity, Inc. (NYSE:RVTY) Q1 2025 Earnings Conference Call April 28, 2025 8:00 AM ETCompany ParticipantsSteve Willoughby - Senior Vice President, Investor...
Source: SeekingAlpha